Skip to main content
Trending storyContinuously updated

Commit Biologics closes €54M seed round led by Ackermans & van Haaren

1 reports1 report sources17 hours agoUpdate

Get up to speed on this story

AI Summary

Copenhagen-based Commit Biologics closed a €54 million ($60 million) seed round led by Ackermans & van Haaren. New investors AbbVie Ventures and M Ventures joined, alongside existing investors Bioqube Ventures, Korys and Novo Holdings. The company said the proceeds will fund IND-enabling work and an IND filing for COM002, its first development candidate announced the prior week, and will move a second program into IND-enabling development while expanding its BiCE pipeline. The funding targets cancer and autoimmune disease therapies.

AI-generated from reports · 18 minutes agoUpdate

Report timeline

Follow the reports to understand different sides of the story.

Nov 17
  1. EU-StartupsTop Deals
    Commit Biologics raises €54M seed to advance cancer and autoimmune therapies

    Copenhagen-based Commit Biologics raised €54 million ($60 million) in seed funding led by Ackermans & van Haaren.

Trend for this story

Not enough continuous observation data yet; trend chart is not drawn for now.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing